{"schema_version":"secwatch.filing_event.v1","accession":"0001401914-26-000010","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2026-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.238303+00:00","generated_at":"2026-05-15T05:30:06.369606+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Gregory W. Matz reclassified from Class II to Class III director to rebalance board classes","bullets":["Matz resigned as Class II director and was reappointed as Class III director effective April 16, 2026.","Reclassification was solely to rebalance the three board classes; service deemed uninterrupted.","Board remains at six members; Matz and Sabrina Martucci Johnson will stand for election at 2026 annual meeting.","No changes to Matz's committee assignments as a result of the reclassification."],"urls":{"canonical":"https://secwatch.observer/filing/0001401914-26-000010","json":"https://secwatch.observer/filing/0001401914-26-000010.json","markdown":"https://secwatch.observer/filing/0001401914-26-000010.md","text":"https://secwatch.observer/filing/0001401914-26-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000010/0001401914-26-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000140191426000010/dare-20260416.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:30:06.369606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}